Table 1 Patients’ and donor characteristics
Radioembolization (n = 44) | TACE (n = 87) | p | |
|---|---|---|---|
Age (years) | 60 [37–70] | 59 [29–69] | 0.1558 |
Male gender (%) | 84.1 | 72.4 | 0.1915 |
MELD score | 12 [6–40] | 10 [6-30] | 0.0204 |
Etiology of liver disease | 0.0434 | ||
Alcohol (%) | 27.3 | 23.0 | |
Hepatitis B (%) | 18.2 | 13.8 | |
Hepatitis C (%) | 25.0 | 50.6 | |
NASH (%) | 18.2 | 6.9 | |
Other (%) | 11.3 | 5.7 | |
Within Milan criteria (%) | 20.5 | 65.5 | < 0.0001 |
AFP pre-treatment (IU/mL) | 22.5 [2.1–13,923.0] | 14.9 [1.5–9860.0] | 0.5369 |
Number of treatments | 1 [1, 2] | 1 [1-7] | 0.0007 |
Donor risk index | 1.740 [1.082–2.484] | 1.680 [0.9420–2.992] | 0.2734 |